Sustained potentiation of AP1 DNA binding is not always associated with neuronal death following systemic administration of kainic acid in murine hippocampus

Neurochemistry International

Volumn 35, Issue 6, 1999, Pages 453-462

  Kitayama, Tomoya ^a   Ogita, Kiyokazu ^a   Yoneda, Yukio ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Activator protein 1; Fos family; Hippocampus; Jun family; Kainic acid; Supershifts

Indexed keywords

PROTEIN C FOS; TRANSCRIPTION FACTOR AP 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; CONTROLLED STUDY; DENTATE GYRUS; DNA BINDING; HIPPOCAMPUS; MALE; MORPHOLOGY; MOUSE; NERVE CELL NECROSIS; NONHUMAN; ONCOGENE C JUN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PYRAMIDAL NERVE CELL;

ANIMALS; APOPTOSIS; DENTATE GYRUS; DIMERIZATION; DNA; GENES, FOS; GENES, JUN; HIPPOCAMPUS; INJECTIONS, INTRAPERITONEAL; KAINIC ACID; MALE; MICE; MICE, MUTANT STRAINS; MULTIGENE FAMILY; NERVE TISSUE PROTEINS; NEUROTOXINS; PROTEIN BINDING; PROTO-ONCOGENE PROTEINS C-FOS; PROTO-ONCOGENE PROTEINS C-JUN; PYRAMIDAL CELLS; STIMULATION, CHEMICAL; TRANSCRIPTION FACTOR AP-1;

MURINAE; VIOLA (ANGIOSPERM);

EID: 0032856484     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(99)00088-1     Document Type: Article

References (35)

1. Azuma Y., Ogita K., Yoneda Y. Particular nuclear transcription factors responsive to systemic administration of kainic acid in murine brain. Neurochem. Int. 29:1996;289-299.
2. Balchen T., Berg M., Diemer N.H. A paradox after systemic kainate injection in rats: lesser damage of hippocampal CA1 neurons after higher doses. Neurosci. Lett. 163:1993;151-154.
3. Bing G., McMillian M., Kim H., Pennypacker K., Feng Z., Qi Q., Kong L-Y., Iadarola M., Hong J.S. Long-term expression of the 35,000 mol. wt. Fos-related antigen in rat brain after kainic acid treatment. Neuroscience. 73:1996;1159-1174.
4. Cameron H.A., McEwen B.S., Gould E. Regulation of adult neurogenesis by excitatory input and NMDA receptor activation in the dentate gyrus. J. Neurosci. 15:1995;4687-4692.
5. Cameron H.A., Woolley C.S., McEwen B., Gould E. Differentiation of newly born neurons and glia in the dentate gyrus of the adult rat. Neuroscience. 56:1993;337-344.
6. Curran T., Franza B.R. Jr. Fos and Jun: the AP1 connection. Cell. 55:1988;395-397.
7. Egebjerg J., Bettler B., Hermans-Borgmeyer I., Heinemann S. Cloning of a cDNA for a glutamate receptor subunit activated by kainate but not AMPA. Nature. 351:1991;745-748.
8. Gall C., Sumikawa K., Lynch G. Levels of mRNA for a putative kainate receptor are affected by seizures. Proc. Natl. Acad. Sci. USA. 87:1990;7643-7647.
9. Good P.F., Huntley G.W., Rogers S.W., Heinemann S.F., Morrison J.H. Organization and quantitative analysis of kainate receptor subunit GluR5-7 immunoreactivity in monkey hippocampus. Brain Res. 624:1993;347-353.
10. Hai T., Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Nat. Acad. Sci. USA. 88:1991;3720-3724.
11. Hibi M., Lin A., Smel T., Minden A., Karin M. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
12. Kaminska B., Filipkowski R.K., Zurkowska G., Lason W., Przewlocki G., Kaczmarek L. Dynamic changes in the composition of the AP-1 transcription factor DNA-binding activity in rat brain following kainate-induced seizures and cell death. Eur. J. Neurosci. 6:1994;1558-1566.
13. Kamphuis W., Hendriksen H., Diegenbach P.C., Lopes Da Silva F.H. N-methyl-D-aspartate and kainate receptor gene expression in hippocampal pyramidal and granular neurons in the kindling model of epileptogenesis. Neuroscience. 67:1995;551-559.
14. Karin M. Signal transduction from cell surface to nucleus in development and disease. FASEB J. 6:1992;2581-2590.
15. Le Gal La Salle G. Long-lasting and sequential increase of c-fos oncoprotein expression in kainic acid-induced status epilepticus. Neurosci. Lett. 88:1988;127-130.
16. Mandelzys A., Gruda M.A., Bravo R., Morgan J.I. Absence of a persistently elevated 37 kDa Fos-related antigen and AP-1-like DNA binding activity in the brains of kainic acid-treated fosB null mice. J. Neurosci. 17:1997;5407-5415.
17. Ogita K., Yoneda Y. Selective potentiation o DNA binding activities of both activator protein-1 and cyclic AMP response element binding protein through in vivo activation of N-methyl-D-aspartate receptor complex in mouse brain. J. Neurochem. 63:1994;525-534.
18. Ogita K., Amizuka T., Azuma Y., Yoneda Y. Differentiation by magnesium ions of affinities of nuclear proteins for consensus core nucleotide element of the transcription factor c-Myc in murine brain. Neurochem. Res. 21:1996;201-209.
19. Olney J.W., Fuller T., de Gubareff T. Acute dendrotoxic changes in the hippocampus of kainate treated rats. Brain Res. 176:1979;91-100.
20. Pennypacker K.R., Hong J-S., McMillan M.K. Pharmacological regulation of AP-1 transcription factor DNA binding activity. FASEB J. 8:1994;475-478.
21. Pennypacker K.R., Thai L., Hong J-S., McMillan M.K. Prolonged expression of AP-1 transcription factors in the rat hippocampus after systemic kainate treatment. J. Neurosci. 14:1994;3998-4006.
22. Popovici T., Represa A., Crepel V., Barbin G., Beadoin M., Ben-Ari Y. Effects of kainic acid-induced seizures and ischemia on c-fos-like proteins in rat brain. Brain Res. 536:1990;183-194.
23. Represa A., Tremblay E., Ben-Ari Y. Kainate binding sites in the hippocampal mossy fibers: localization and plasticity. Neuroscience. 20:1987;739-748.
24. Sakurai-Yamashita Y., Sassone-Corsi P., Gombos G. Immunohistochemistry of c-fos in mouse brain during postnatal development: basal levels and changing response to metrazol and kainate. Eur. J. Neurosci. 3:1991;764-770.
25. Sassone-Corsi P., Sisson J.C., Verma I.M. Transcriptional autoregulation of the proto-oncogene fos. Nature. 334:1988;314-319.
26. Schreiber E., Matthias P., Müller M.M., Schaffner W. Rapid detection of octamer binding proteins with 'mini-extract', prepared from a small number of cells. Nucleic Acids Res. 17:1989;6419.
27. Sola C., Tusell J.M., Seratosa J. Differential response of calmodulin genes in the mouse brain after systemic kainate administration. Neuroscience. 78:1997;155-164.
28. Sonnenberg J.L., Mitchelmore C., Macgregor-Leon P.F., Hempstead J., Morgan J.I., Curran T. Glutamate receptor agonists increase the expression of Fos, Fra, and AP-1 DNA binding activity in the mammalian brain. J. Neurosci. Res. 24:1989;72-80.
29. Willoughby J.O., Mackenzie L., Medvedev A., Hiscock J.J. Fos induction following systemic kainic acid: early expression in hippocampus and later widespread expression correlated with seizure. Neuroscience. 77:1997;379-392.
30. 3H]glutamate receptor binding assays. Anal. Biochem. 177:1989;250-255.
31. Yoneda Y., Ogita K. Rapid and selective enhancement of DNA binding activity of the transcription factor AP1 by systemic administration of N-methyl-D-aspartate in murine hippocampus. Neurochem. Int. 25:1994;263-271.
32. Yoneda Y., Ogita K., Kabuto H., Mori A. Selectively high expression of the transcription factor AP1 in telencephalic structures of epileptic El mice. Neurosci. Lett. 161:1993;161-164.
33. Yoneda Y., Ogita K., Azuma Y., Ikeda M., Tagami H., Manabe T. N-methyl-D-aspartate signaling to nuclear activator protein-1 through mechanisms different from those for kainate in murine brain. Neuroscience. 90:1999;519-533.
34. Yoneda Y., Ogita K., Inoue K., Mitani A., Zhang L., Masuda S., Higashihara M., Kataoka K. Rapid potentiation of DNA binding activities of particular transcription factors with leucine-zipper motifs in discrete brain structures of the gerbil with transient forebrain ischemia. Brain Res. 667:1994;54-66.
35. Yoneda Y., Azuma Y., Inoue K., Ogita K., Mitani A., Zhang L., Masuda S., Higashihara M., Kataoka K. Positive correlation between prolonged potentiation of binding of double stranded oligonucleotide probe for the transcription factor AP1 and resistance to transient forebrain ischemia in gerbil hippocampus. Neuroscience. 79:1997;1023-1037.